STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Monopar Therapeutics (Nasdaq: MNPR) has announced its participation in the 36th Annual Piper Sandler Healthcare Conference. CEO Chandler Robinson will engage in a fireside chat and one-on-one meetings at the event. The presentation is scheduled for December 5, 2024, from 10:30-10:55 am Eastern Time at the Lotte New York Palace in New York. Monopar is a clinical-stage biotechnology company that develops innovative treatments for patients with unmet medical needs.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

WILMETTE, Ill., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will participate in a fireside chat along with one-on-one meetings at the 36th Annual Piper Sandler Healthcare Conference.

Presentation Details:

Date: December 5, 2024
Time: 10:30-10:55 am Eastern Time
Location: Lotte New York Palace, NY, NY

About Monopar Therapeutics Inc.

Monopar Therapeutics is a clinical-stage biotechnology company with late-stage ALXN-1840 for Wilson disease, and radiopharma programs including Phase 1-stage MNPR-101-Zr for imaging advanced cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac225 for the treatment of advanced cancers. For more information, visit: www.monopartx.com.

CONTACT:  

Monopar Therapeutics Inc.
Investor Relations  
Karthik Radhakrishnan
Chief Financial Officer  
karthik@monopartx.com

Follow Monopar on social media for updates: 
Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics


FAQ

When is Monopar Therapeutics (MNPR) presenting at the Piper Sandler Healthcare Conference 2024?

Monopar Therapeutics (MNPR) is presenting on December 5, 2024, from 10:30-10:55 am Eastern Time at the Lotte New York Palace in New York.

What type of presentation will MNPR give at the Piper Sandler Healthcare Conference?

MNPR's CEO Chandler Robinson will participate in a fireside chat and conduct one-on-one meetings at the conference.

Where is the 36th Annual Piper Sandler Healthcare Conference being held for MNPR's presentation?

The conference is being held at the Lotte New York Palace in New York, NY.

What is the main focus of Monopar Therapeutics (MNPR) as mentioned in the announcement?

Monopar Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs.
Monopar Therapeutics Inc

NASDAQ:MNPR

MNPR Rankings

MNPR Latest News

MNPR Latest SEC Filings

MNPR Stock Data

591.21M
5.09M
34.25%
51.83%
2.21%
Biotechnology
Pharmaceutical Preparations
Link
United States
WILMETTE